Roche to Pilot Linguamatics for Molecular Genomics Research
News Feb 23, 2006
I2E will be deployed to help with a wide range of knowledge discovery tasks at the Roche Center for Medical Genomics in Basel, Switzerland.
The technology is designed to enable the discovery of key information from large collections of text documents that would be impossible or prohibitively time-consuming to find using conventional methods.
The system's linguistic capabilities can be used interactively to extract relevant facts and relationships from unstructured text documents and present them to the user in a structured form.
Commenting on the relationship, Roger Hale, COO of Linguamatics, said, "This is an ideal application for the I2E system."
"Its Information Extraction capabilities, combined with its speed and ease of use, allow users to get the answers they need very quickly without requiring linguistic expertise. We are very pleased to be working with Roche, and look forward to a successful collaboration."
Guillemette Duchateau-Nguyen, Leader of the Text Mining tools evaluation project at the Roche Center for Medical Genomics, said, "In our search for appropriate text mining tools to aid our research, we were very impressed by the capabilities of Linguamatics’ I2E system, in particular its flexibility and ease of use."
"We are looking forward to gaining new insights from the literature and our internal information resources through our use of I2E."
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE